Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency.

NCT02229851 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

301

Enrollment

INDUSTRY

Sponsor class

Conditions

Growth Hormone Disorder
Adult Growth Hormone Deficiency

Interventions

DRUG: somapacitan
DRUG: somatropin
DRUG: placebo

Sponsor

Novo Nordisk A/S